Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Clinics in Laboratory Medicine|September 4, 2012
The utility of immunoassays for urine drug testingStacy E F MelansonClinics in Laboratory Medicine|October 21, 2009
Drug-of-abuse testing at the point of careStacy E F MelansonClinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2013
Establishing benchmarks and metrics for utilization managementStacy E F MelansonThe Journal of Applied Laboratory Medicine|February 27, 2021
Economics of Pain Management TestingStacy E F Melanson, Athena K PetridesAmerican Journal of Clinical Pathology|February 14, 2006
Laboratory testing for B-type natriuretic peptides (BNP and NT-proBNP): clinical usefulness, utilization, and impact on hospital operationsStacy E F Melanson, Elizabeth Lee LewandrowskiProceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1997
Experiences in deployment of a Web-based CIS for referring physiciansR Kittredge, U Rabbani, F Melanson, et al.Clinical Chemistry and Laboratory Medicine|July 11, 2009
Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspectiveStacy E F Melanson, Maria I Kredlow, Petr JarolimClinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2011
A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl complianceMarion L Snyder, Petr Jarolim, Stacy E F MelansonAmerican Journal of Clinical Pathology|July 20, 2007
Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivityStacy E F Melanson, David A Morrow, Petr JarolimArchives of Pathology & Laboratory Medicine|July 10, 2007
Selecting automation for the clinical chemistry laboratoryStacy E F Melanson, Neal I Lindeman, Petr JarolimPageof 8